企業プロフィール
Heron Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- HRTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.32 USD (-4.96%)
終値
最終更新: 2026年8月17日
85.2M USD
時価総額
株価変動の要因
As of Aug 17, 2026, HRTX closed down 4.96% at $0.3200. No new same-company headline was identified in the current news window.
企業概要
Acute-Care Medicines
Heron Therapeutics commercializes medicines used in surgical pain management and oncology supportive care. Its portfolio is designed for administration in hospitals, ambulatory surgery centers and infusion settings.
ZYNRELEF
ZYNRELEF is an extended-release local anesthetic combining bupivacaine and meloxicam for postoperative pain. Heron is developing a ready-to-use prefilled syringe intended to improve preparation and operating-room efficiency.
Oncology Supportive Care
CINVANTI and APONVIE are injectable antiemetic products used to prevent nausea and vomiting associated with chemotherapy or surgery. These products complement the company's acute-care commercial infrastructure.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。